David P. Bonita is Director at Repare Therapeutics Inc. (RPTX). They have made 31 open-market trades across 12 companies since 2013, most recently 2026-04-21.
CIK 0001572451
20 open-market purchases totalling $162.0M since 2013, against 11 sales. Across 18 scored buys the stock is up 5.3% at ninety days, and 0.3 points ahead of the S&P over the same stretch.
18 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 61% | 39% | 33% |
| Avg Move | +3.0% | +0.4% | +5.3% |
| Alpha | +2.1% | -1.6% | +0.3% |
| Scored | 18 | 18 | 18 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRLD | BUY | 2026-04-21 | 2026-04-23 | $4.44 | $12.5M | -3.7% | -16.5% | -19.2% |
| IMA | BUY | 2025-07-25 | 2025-07-30 | $29.90 | $5.0M | -7.9% | -16.3% | -45.7% |
| PRLD | BUY | 2023-05-22 | 2023-05-24 | $5.75 | $10.0M | +2.7% | -15.5% | -40.6% |
| TCDA | SELL | 2022-11-22 | 2022-11-25 | $0.22 | $3.2M | +7.5% | -38.3% | N/A |
| THRD | BUY | 2022-09-19 | 2022-09-21 | $17.00 | $5.1M | +0.7% | +2.5% | -76.3% |
| IKNA | BUY | 2022-06-22 | 2022-06-24 | $4.47 | $1.1M | -9.0% | -3.7% | -33.5% |
| RPTX | SELL | 2021-09-03 | 2021-09-08 | $33.99 | $275K | -10.2% | -35.1% | -27.8% |
| RPTX | SELL | 2021-08-31 | 2021-09-02 | $34.08 | $2.5M | -10.5% | -23.6% | -41.0% |
| RPTX | SELL | 2021-08-26 | 2021-08-30 | $34.10 | $993K | -4.3% | -23.3% | -27.6% |
| RPTX | SELL | 2021-08-23 | 2021-08-25 | $34.17 | $1.2M | -8.4% | -19.3% | -26.0% |
| RPTX | SELL | 2021-08-17 | 2021-08-25 | $34.10 | $1.4M | -8.4% | -19.3% | -26.0% |
| AFIB | BUY | 2021-07-19 | 2021-07-21 | $14.00 | $15.0M | +2.5% | -12.6% | -44.6% |
| IMRA | BUY | 2021-07-16 | 2021-07-23 | $6.00 | $10.0M | +0.2% | -17.6% | -35.4% |
| IKNA | BUY | 2021-03-30 | 2021-04-14 | $16.00 | $6.8M | +19.0% | -0.9% | -31.2% |
| PRLD | BUY | 2020-09-25 | 2020-09-30 | $19.00 | $23.5M | +40.4% | +12.0% | +167.5% |
| AFIB | BUY | 2020-08-10 | 2020-08-12 | $18.00 | $7.5M | +8.7% | +35.4% | -0.9% |
| RPTX | BUY | 2020-06-23 | 2020-06-25 | $20.00 | $15.5M | -14.8% | -34.0% | -0.8% |
| IMRA | BUY | 2020-03-12 | 2020-03-16 | $16.00 | $15.0M | +3.0% | +0.4% | +150.4% |
| TCDA | SELL | 2019-12-11 | 2019-12-12 | $40.00 | $60.0M | -0.1% | -8.9% | -29.0% |
| TCDA | BUY | 2019-04-03 | 2019-04-05 | $36.00 | $8.1M | -14.1% | -6.0% | -2.6% |
| SIBN | BUY | 2018-10-19 | 2018-10-19 | $15.00 | $3.0M | -7.9% | -17.5% | +9.8% |
| TCDA | BUY | 2018-07-02 | 2018-07-02 | $19.00 | $7.0M | -4.3% | -24.5% | -0.9% |
| LOXO | SELL | 2017-12-08 | 2017-12-12 | $82.50 | $20.6M | +5.9% | +8.2% | +57.0% |
| LOXO | SELL | 2017-11-22 | 2017-11-27 | $75.00 | $20.0M | +6.7% | +15.5% | +51.0% |
| LOXO | SELL | 2017-11-16 | 2017-11-20 | $74.33 | $36.9M | -1.0% | +4.2% | +34.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| TCDA | 9,246,526 | $999K |
| RPTX | 96,216 | $255K |
| AFIB | 20,822 | $2K |
| VRAY | 26,388 | $660 |
| AMBI | 14,067 | — |
| Total | $300.7M |
Shares reported on the most recent Form 4, priced at the 2026-04-23 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.